Detalles de la búsqueda
1.
Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome.
Rheumatology (Oxford)
; 60(5): 2396-2408, 2021 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33221921
2.
Baricitinib set to join the Covid-19 therapeutic arsenal?
Rheumatology (Oxford)
; 60(4): 1585-1587, 2021 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502499
3.
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial.
Lancet Respir Med
; 11(12): 1064-1074, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37977159
4.
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.
NEJM Evid
; 1(1): EVIDoa2100009, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319239
5.
Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects.
Eur J Drug Metab Pharmacokinet
; 46(1): 71-83, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33165774
6.
Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study.
BMJ Open
; 11(4): e037457, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849844
7.
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial.
Trials
; 21(1): 690, 2020 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32736592
8.
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 626, 2020 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32641154
10.
Effect of rifabutin on the pharmacokinetics of oral cabotegravir in healthy subjects.
Antivir Ther
; 24(4): 301-308, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30896438
11.
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial.
BMJ Open
; 8(9): e022452, 2018 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30224390
Resultados
1 -
11
de 11
1
Próxima >
>>